Femtobiomed Inc. (XKON: 327610)

Market Cap	47.08B
Revenue	n/a
Net Income	n/a
Shares Out	8.26M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,865
Open	6,000.00
Previous Close	6,000.00
Day's Range	5,300.00 - 6,000.00
52-Week Range	4,615.00 - 10,790.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Femtobiomed

Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research. The company was founded in 2011 and is based in Seongnam-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2011
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 327610